cancer therapy matrix metalloproteinase inhibitors cancer: trials tribulations
least years matrix metalloproteinases mmps heralded promising targets cancer therapy basis massive up-regulation malignant tissues unique ability degrade components extracellular matrix preclinical studies testing efficacy mmp suppression tumor models compelling synthetic metalloproteinase inhibitors mpis rapidly developed routed human clinical trials results trials disappointing review studies brought mpis clinical testing discuss design outcome trials tight new information cellular source substrates mode action mmps different stages tumor progression important lessons learned mpi experience may great value future studies mpis cancer drug development general
